S
Steven Charles Falchuk
Researcher at Christiana Care Health System
Publications - 3
Citations - 213
Steven Charles Falchuk is an academic researcher from Christiana Care Health System. The author has contributed to research in topics: Placebo & Donepezil. The author has an hindex of 3, co-authored 3 publications receiving 176 citations.
Papers
More filters
Journal ArticleDOI
Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial
Stephen R. Rapp,L. Doug Case,Ann M. Peiffer,Michelle M. Naughton,Michael D. Chan,Volker W. Stieber,Dennis F. Moore,Steven Charles Falchuk,James Piephoff,William Jeffery Edenfield,Jeffrey K. Giguere,Monica Loghin,Edward G. Shaw +12 more
TL;DR: Treatment with donepezil did not significantly improve the overall composite score, but it did result in modest improvements in several cognitive functions, especially among patients with greater pretreatment impairments.
Journal ArticleDOI
Phase III randomized, double-blind, placebo-controlled trial of donepezil in irradiated brain tumor survivors.
Stephen R. Rapp,Doug Case,Ann M. Peiffer,Michelle J. Naughton,Volker W. Stieber,Gerald K. Bayer,Paul A. Bilodeau,Dennis F. Moore,Steven Charles Falchuk,Burton M. Needles,James Piephoff,William Jeffery Edenfield,Jeffrey K. Giguere,Nicholette Erickson,Monica Loghin,Edward G. Shaw +15 more
TL;DR: Cognitive function was assessed at baseline, 12 and 24 weeks with Hopkins Verbal Learning Test-Revised, Rey-Osterreith Complex Figure, Trail Making Test, Digit Span, Controlled Oral Word Association, and Grooved Pegboard.
Journal ArticleDOI
Quality of life of irradiated brain tumor survivors treated with donepezil or placebo: Results of the WFU CCOP research base protocol 91105.
Michelle J. Naughton,L. Douglas Case,Ann M. Peiffer,Michael D. Chan,Volker W. Stieber,Dennis F. Moore,Steven Charles Falchuk,James Piephoff,William Jeffery Edenfield,Jeffrey K. Giguere,Monica Loghin,Edward G. Shaw,Stephen R. Rapp +12 more
TL;DR: The positive impact of donepezil on HRQL was greater in survivors reporting more baseline cognitive symptoms, andDonepezil had significantly worse effects on fatigue and functional well-being among participants with fewer baseline symptoms.